Navigation Links
Undergrad has sweet success with invention of artificial Golgi

Troy, N.Y. An undergraduate student at Rensselaer Polytechnic Institute has learned very quickly that a spoonful of sugar really does help the medicine go down. In fact, with his invention, the sugar may actually be the medicine.

Among the most important and complex molecules in the human body, sugars control not just metabolism but also how cells communicate with one another. Graduating senior Jeffery Martin has put his basic knowledge of sugars to exceptional use by creating a lab-on-a-chip device that builds complex, highly specialized sugar molecules, mimicking one of the most important cellular structures in the human body the Golgi Apparatus.

Almost completely independently he has been able to come closer than researchers with decades more experience to creating an artificial Golgi, said Robert Linhardt, the Ann and John H. Broadbent Jr. 59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer and Martins adviser. He saw a problem in the drug discovery process and almost instantly devised a way to solve it.

Cells build sugars in a cellular organelle known as the Golgi Apparatus. Under a microscope, the Golgi looks similar to a stack of pancakes. The strange-looking organelle finishes the process of protein synthesis by decorating the proteins with highly specialized arrangements of sugars. The final sugar-coated molecule is then sent out into the cell to aid in cell communication and to help determine the cells function in the body.

Martins artificial Golgi functions in a surprisingly similar way to the natural Golgi, but he gives the ancient organelle a very high-tech makeover. His chip looks similar to a miniature checker board where sugars, enzymes, and other basic cell materials are suspended in water and can be transported and mixed by applying electric currents to the destination squares on the checker board. Through this process sugars can be built in an automated fashion where they are exposed to a variety of enzymes found in the natural Golgi. The resulting sugars can then be tested on living cells either on the chip or in the lab to determine their effects. With the chips ability to process many combinations of sugars and enzymes, it could help researchers quickly uncover new sugar-based drugs, according to Martin.

Scientists have known for years that certain sugars can serve as extremely beneficial therapeutics for humans. One well-known example is heparin, which is among the most widely used drugs in the world. Heparin is formed naturally in the Golgi organelle in cells of the human body as well as in other animals like pigs. Heparin acts as an anticoagulant preventing blood clots, which makes it a good therapeutic for heart, stroke, and dialysis patients.

The main source of heparin is currently the intestines of foreign livestock and, as recent news reports highlight, the risk of contamination from such sources is high. So researchers are working around the clock to develop a safer, man-made alternative to the drug that will prevent outside contamination. A synthetic alternative would build the sugar from scratch, helping eliminate the possibility of contamination he explained.

I am very grateful to have the privilege of working with Dr. Linhardt who has discovered the recipe to make fully synthetic heparin, Martin said. Because we know the recipe, I am going to use it as a model to test the device. If our artificial Golgi can build fully functional heparin, we can then use the artificial organelle to produce many different sugar variants by altering the combination of enzymes used to synthesize them. Another great thing about these devices is that they are of microscale size, so that if needed we could fill an entire room with them to increase throughput for drug discovery.

There are millions of possible sugar combinations that can be formed and scientists currently only know the function of very few of them like heparin. Since it is known that these types of sugars play a part in many important biological processes such as cell growth, cell differentiation, blood coagulation, and viral defense mechanisms, we feel that that this artificial Golgi will help our team to develop a next generation of sugar-based drugs, known as glycotheraputics, Martin said. We are going to start making new combinations and we simply dont know what we are going to find. We could find a sugar whose signal blocks the spread of cancer cells or initiates the differentiation of stem cells. We just dont know.


Contact: Gabrielle DeMarco
Rensselaer Polytechnic Institute

Related biology news :

1. ASPB announces Summer Undergraduate Research Fellowship 2007 recipients
2. Woods Hole Research Center to lead undergraduate initiative in the Siberian Arctic
3. BGSU undergraduates to pilot groundbreaking genome project
4. Computational mathematical sciences receives NSF grant for undergraduate research
5. Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest
6. Undergraduate bioscience research reaches new horizons
7. Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences
8. To maximize biofuel potential, researchers look for sorghums sweet spot
9. Sweet smell
10. Sweet potato shines as new promise for small enterprise and hunger relief in developing countries
11. How sweet is it?
Post Your Comments:
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 ... is dominated by a few companies, according to Kalorama ... own 51% of the market share of the 6.1 ... The World Market for Molecular Diagnostic s . ... "The market is still controlled by one company and ...
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  CardioCell LLC, ... allogeneic stem cells for cardiovascular indications, intends to ... protocol based on recommendations from a Heart Failure ... its Scientific Advisory Board members . In ... preliminary Phase IIa safety and efficacy data from ...
(Date:12/1/2015)... 1, 2015 Cepheid (Nasdaq: CPHD ) ... the Piper Jaffray Healthcare Conference in New ... is reaffirming its outlook for the fourth quarter of ... to discussing longer term business model expectations. ...  "We continue to be the fastest growing company of ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells ... aesthetics professionals from Central America and abroad for the first Iberoamerican Convention on ... Feb. 17-19, 2016. Testart will present and discuss new trends in anti-aging stem ...
(Date:11/30/2015)... Inc. (NYSE: BIOA ), a leader in renewable materials, ... on Climate Pledge, alongside more than 140 companies from across ... to demonstrate an ongoing commitment to climate action and to ... Paris climate negotiations. Sarnia, ... . --> BioAmber uses biotechnology to convert renewable ...
Breaking Biology Technology: